Scalper1 News
Medical giant Johnson & Johnson (JNJ) got the Q3 earnings season off to a shaky start for medical stocks Tuesday, missing revenue estimates and beating EPS views only due to a lower tax rate. J&J said earnings totaled $1.49 a share excluding one-time items, down 7.5% from the year-earlier quarter but beating analysts’ consensus by 4 cents, according to Thomson Reuters. Revenue shrank 7.4% to $17.1 billion, some $350 million short of consensus. The Scalper1 News
Scalper1 News